Diligence memo · auto-generated · as of July 2, 2026

Neuro-Innovators LLC

Neuro-Innovators LLC looks fair against its niche peers and is quiet on financing cadence.

SourceRaising on rhythm with a 5.4× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Neuro-Innovators LLC operates in Pharmaceuticals, based in SEWICKLEY.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Neuro-Innovators LLC has raised $640K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $540K on 2025-01-10.

Most recent recorded round closed around 2025-01-10.

Valuation (modeled)modeled

Provath models Neuro-Innovators LLC at approximately $1.8M (range $303K–$5.1M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.23× the median modeled value of Pre-Seed Pharmaceuticals companies in 2025–2027 (19 peers) — value vs value, same stage and era. Within the normal band (123% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 25 months.

Last raise 18 mo ago; this sector typically re-raises about every 13 months.

Slightly overdue versus sector cadence.

The last round stepped up 5.4× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 15% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 4% of those peers.

Closest niche peers: Fedora Pharmaceuticals Inc., PRG FlowChem, Inc., Adora Animal Health Corp, ABLi Therapeutics, Inc., NextEvo, Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.